Opioid Induced Constipation Drugs Market is Estimated to Grow at a USD 4.23 Million During the Forecast Period 2030
While creating Opioid Induced Constipation Drugs Market research report, marketing administration has carefully considered the minds of their target markets, their feelings, their preferences, their attitudes, convictions and value systems with a formalised and managerial approach. For the accomplishment of business at local, regional and international level, this high quality global market research is an ultimate solution. The research studies accomplished in the wide ranging Opioid Induced Constipation Drugs Market business report helps to guess several important aspects that includes but are not limited to investment in a rising market, success of a new product, and expansion of market share.
The global opioid-induced constipation drugs market is estimated to witness significant growth during the forecast period. The prolonged use of opioids can harm the sensory system which causes body cells to quit creating endogenous opioids, such as endorphins. Adults have a huge risk of constipation as they tend to have a poor diet, poor fluid intake, and immobility. Generally, the patients opt for over-the-counter osmotic laxatives and stimulant cathartics, which have been beneficial in relieving constipation in patients taking opioid analgesics for 3-4 weeks.
Data Bridge Market Research analyses a growth rate in the opioid induced constipation drugs market in the forecast period 2023-2030. The expected CAGR of opioid induced constipation drugs market tends to be around 6.7% in the mentioned forecast period. The market was valued at USD 2.52 million in 2022, and it would grow up to USD 4.23 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
The opioid-induced constipation is a type of condition that is generally triggered after the consumption of opioid pain medications such as morphine, codeine, hydrocodone, and others. The therapeutic effect of these medicines is very useful in pain relieving, though it leads to specific types of constipation in the majority of cases. The attachment of the opioids with the receptors in the gut lengthens the amount of time for stool to pass through the gastrointestinal system. This causes a condition in which bowel movements are reduced to three times a week. Thus, proper treatment is needed to relieve this condition’s pain.
Download the Exclusive Sample Report (Including Graphs, Charts & Table & Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-opioid-induced-constipation-drugs-market
Global Opioid-Induced Constipation Drugs Market Dynamics
Drivers
Rising Incidence of Kidney Diseases
The rise in kidney disorders can be attributed to lifestyle changes such as consuming unhealthy food high in calcium and other minerals. For instance, per the records of the global burden disease 2015 study, around 1.2 million people in the world died due to kidney failure in 2015, a 32% rise since 2005. Thus, this boosts market growth.
Increasing Diversified Treatments
Several diversified treatments are available for the diseased condition and thus are contributing to boosting the market growth. Lubiprostone is indicated for treating opioid-induced constipation drugs, with its major indication for chronic idiopathic constipation (CIC). Lubiprostone is anticipated to take over the market share of methylnaltrexone bromide. Furthermore, naloxegol is projected to grow at the highest CAGR during the forecast period. The drug is under testing for many patient types, such as pregnant women and patients less than 17 years of age. So, future approvals are estimated to dominate the market.
Opportunities
Increasing Demand for Retail Pharmacies
The increase in opioid-induced constipation drugs delivered through retail pharmacies and the increase in the number of pharmacies in highly developed countries create opportunities for market growth. Additionally, patients prefer retail pharmacies for purchasing drugs, as these are easily available.
Increasing Use of Opioids
In 2014, it was reported that more than six out of 10 deaths were due to opioid overdose, which included heroin and opioid pain relievers. The maximum number of deaths witnessed because of synthetic variants, that included 5,500 deaths in 2014. Considering the increased death rate related to opioid dependency and abuse, governments in the US and other countries advocate against using these substances. Thus, it creates an opportunity for market growth.
Global Opioid Induced Constipation Drugs Market Scope
The global opioid induced constipation drugs market is segmented on the basis of active ingredient, treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Active Ingredients
Naloxegol
Lubiprostone
Methylnaltrexone Bromide
Docusate Sodium
Others
Treatment
Over The Counter Medicines
Prescription, Natural Remedies
Route of Administration
Oral
Parenteral
Others
End-Users
Hospitals
Homecare
Speciality Centres
Others
Distribution Channel
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
To Get a Detailed Table of Contents (TOC), please Click Here at @ https://www.databridgemarketresearch.com/toc/?dbmr=global-opioid-induced-constipation-drugs-market
Opioid Induced Constipation Drugs Market Regional Analysis/Insights
The global opioid induced constipation drugs market is analyzed and market size insights and trends are provided by active ingredient, treatment, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the global opioid induced constipation drugs market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is expected to have the highest market growth due to key product manufacturers’ presence, increasing research and development activities and healthcare expenditure.
Asia-Pacific dominates the market due to increased new research and developments on opioid-induced constipation drugs market. The increased availability of advanced healthcare infrastructure and earlier approval of opioid induced constipation drugs due to the accelerated drug approval initiative by the U.S. FDA is likely to boost the market growth in this region
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Opioid Induced Constipation Drugs Market Share Analysis
The global opioid induced constipation drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to global opioid induced constipation drugs market.
Key players operating in the global opioid induced constipation drugs market include:
Pfizer Inc (US.)
F. Hoffmann-La Roche Ltd (Switzerland)
Mylan N.V. (U.S.)
Fresenius Kabi AG (Germany)
Hikma Pharmaceuticals PLC (UK.)
Novartis AG (Switzerland)
Teva Pharmaceutical Industries Ltd. (Israel)
Bristol Myers Squibb Company (US.)
GSK Plc. (UK.)
Bayer AG (Germany)
Aurobindo Pharma (India)
S.L.A. Pharma AG (U.K)
Salix Pharmaceuticals (US.)
Takeda Pharmaceutical Company Limited (Japan)
Abbott(US.)
Boehringer Ingelheim International GmbH. (Germany)
Merck & Co Inc. (US.)
Daewoong Pharmaceutical Company (South Korea)
Cosmo Pharmaceuticals (Ireland)
Browse a Detailed Summary of the Research Report @ https://www.databridgemarketresearch.com/reports/global-opioid-induced-constipation-drugs-market
Research Methodology:
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Top Trendings Reports:-
https://www.databridgemarketresearch.com/reports/global-vendor-neutral-archive-vna-market
https://www.databridgemarketresearch.com/reports/global-anesthesia-monitoring-devices-market
https://www.databridgemarketresearch.com/reports/global-point-of-care-molecular-diagnostics-market
https://www.databridgemarketresearch.com/reports/global-cell-permeabilization-market
https://www.databridgemarketresearch.com/reports/global-tangential-flow-filtration-market
About Data Bridge Market Research, Private Ltd
Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability levels and advanced approaches. We are committed to uncovering the best consumer prospects and fostering useful knowledge for your company to succeed in the market.
Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expanded its reach by opening a new office in the Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”
Contact us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Corporatesales@databridgemarketresearch.com
